Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Iwanicki, MP"'
Autor:
Davidowitz, RA, Selfors, LM, Iwanicki, MP, Elias, KM, Karst, A, Piao, H, Ince, TA, Drage, MG, Dering, J, Konecny, GE, Matulonis, U, Mills, GB, Slamon, DJ, Drapkin, R, Brugge, JS
Publikováno v:
The Journal of clinical investigation, vol 124, iss 6
Davidowitz, RA; Selfors, LM; Iwanicki, MP; Elias, KM; Karst, A; Piao, H; et al.(2014). Mesenchymal gene program-expressing ovarian cancer spheroids exhibit enhanced mesothelial clearance. Journal of Clinical Investigation, 124(6), 2611-2625. doi: 10.1172/JCI69815. UCLA: Retrieved from: http://www.escholarship.org/uc/item/4q50b4b6
Davidowitz, RA; Selfors, LM; Iwanicki, MP; Elias, KM; Karst, A; Piao, H; et al.(2014). Mesenchymal gene program-expressing ovarian cancer spheroids exhibit enhanced mesothelial clearance. Journal of Clinical Investigation, 124(6), 2611-2625. doi: 10.1172/JCI69815. UCLA: Retrieved from: http://www.escholarship.org/uc/item/4q50b4b6
Metastatic dissemination of ovarian tumors involves the invasion of tumor cell clusters into the mesothelial cell lining of peritoneal cavity organs; however, the tumor-specific factors that allow ovarian cancer cells to spread are unclear. We used a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::77edaf11f963ee4aa2dfaad5e2084ea2
https://escholarship.org/uc/item/4q50b4b6
https://escholarship.org/uc/item/4q50b4b6
Autor:
Reavis HD; Penn Ovarian Cancer Research Center, Department of Obstetrics and Gynecology.; Cell and Molecular Biology Graduate Group; and.; Department of Cancer Biology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA., Gysler SM; Penn Ovarian Cancer Research Center, Department of Obstetrics and Gynecology., McKenney GB; Penn Ovarian Cancer Research Center, Department of Obstetrics and Gynecology., Knarr M; Penn Ovarian Cancer Research Center, Department of Obstetrics and Gynecology., Lusk HJ; Department of Chemistry and Biochemistry, University of California, Santa Cruz, Santa Cruz, California, USA., Rawat P; Penn Ovarian Cancer Research Center, Department of Obstetrics and Gynecology., Rendulich HS; Penn Ovarian Cancer Research Center, Department of Obstetrics and Gynecology., Mitchell MA; Penn Ovarian Cancer Research Center, Department of Obstetrics and Gynecology., Berger DS; Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA., Moon JS; Department of Translational Molecular Medicine and Sequencing Center, Saint John's Cancer Institute, Providence Health Services, Santa Monica, California, USA., Ryu S; Department of Translational Molecular Medicine and Sequencing Center, Saint John's Cancer Institute, Providence Health Services, Santa Monica, California, USA., Mainigi M; Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA., Iwanicki MP; Departments of Bioengineering, Chemistry, and Chemical Biology and Biological Sciences, Stevens Institute of Technology, Hoboken, New Jersey, USA., Hoon DS; Department of Translational Molecular Medicine and Sequencing Center, Saint John's Cancer Institute, Providence Health Services, Santa Monica, California, USA., Sanchez LM; Department of Chemistry and Biochemistry, University of California, Santa Cruz, Santa Cruz, California, USA., Drapkin R; Penn Ovarian Cancer Research Center, Department of Obstetrics and Gynecology.; Basser Center for BRCA, Abramson Cancer Center, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA.
Publikováno v:
JCI insight [JCI Insight] 2024 Mar 08; Vol. 9 (5). Date of Electronic Publication: 2024 Mar 08.
Autor:
Doberstein K; Ovarian Cancer Research Center, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA, 19104, USA.; Department of Gynecology, Medical Faculty Mannheim of the Heidelberg University, Mannheim, Germany., Spivak R; Ovarian Cancer Research Center, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA, 19104, USA., Reavis HD; Ovarian Cancer Research Center, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA, 19104, USA., Hooda J; Ovarian Cancer Research Center, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA, 19104, USA.; University of Pittsburgh, Hillman Cancer Center, Pittsburgh, PA, USA., Feng Y; Ovarian Cancer Research Center, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA, 19104, USA., Kroeger PT Jr; Ovarian Cancer Research Center, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA, 19104, USA., Stuckelberger S; Ovarian Cancer Research Center, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA, 19104, USA., Mills GB; Knight Cancer Institute, Oregon Health and Science University, Portland, OR, 97239, USA., Devins KM; Department of Pathology and Laboratory Medicine, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA, 19104, USA., Schwartz LE; Department of Pathology and Laboratory Medicine, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA, 19104, USA., Iwanicki MP; Department of Bioengineering, Chemistry, Chemical Biology and Biological Sciences, Stevens Institute of Technology, Hoboken, NJ, USA., Fogel M; Central Laboratories, Kaplan Medical Center, Rehovot, Israel., Altevogt P; Skin Cancer Unit, German Cancer Research Center (DKFZ), Heidelberg, Germany., Drapkin R; Ovarian Cancer Research Center, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA, 19104, USA. rdrapkin@pennmedicine.upenn.edu.; Basser Center for BRCA, Abramson Cancer Center, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA, 19104, USA. rdrapkin@pennmedicine.upenn.edu.
Publikováno v:
Communications biology [Commun Biol] 2022 Dec 12; Vol. 5 (1), pp. 1362. Date of Electronic Publication: 2022 Dec 12.
The Interplay of the Extracellular Matrix and Stromal Cells as a Drug Target in Stroma-Rich Cancers.
Autor:
Kozlova N; Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA, USA., Grossman JE; Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA, USA., Iwanicki MP; Chemistry and Chemical Biology, Stevens Institute of Technology, Hoboken, NJ, USA., Muranen T; Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA, USA. Electronic address: tmuranen@bidmc.harvard.edu.
Publikováno v:
Trends in pharmacological sciences [Trends Pharmacol Sci] 2020 Mar; Vol. 41 (3), pp. 183-198. Date of Electronic Publication: 2020 Jan 31.
Autor:
Eriksson M; Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden., Ambroise G; Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden., Ouchida AT; Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden., Lima Queiroz A; Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden., Smith D; Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden., Gimenez-Cassina A; Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden.; Departamento de Biología Molecular, Universidad Autónoma de Madrid, Centro de Biología Molecular Severo Ochoa (CSIC-UAM), Madrid, Spain., Iwanicki MP; Department of Cell Biology, Harvard Medical School, Boston, Massachusetts, USA., Muller PA; MRC Toxicology Unit, University of Leicester, Leicester, United Kingdom., Norberg E; Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden Erik.Norberg@ki.se Helin.norberg@ki.se., Vakifahmetoglu-Norberg H; Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden Erik.Norberg@ki.se Helin.norberg@ki.se.
Publikováno v:
Molecular and cellular biology [Mol Cell Biol] 2017 Nov 28; Vol. 37 (24). Date of Electronic Publication: 2017 Nov 28 (Print Publication: 2017).
Autor:
Muranen T; Department of Cell Biology, Harvard Medical School, Boston, Massachusetts 02115, USA., Iwanicki MP; Department of Cell Biology, Harvard Medical School, Boston, Massachusetts 02115, USA., Curry NL; Division of Endocrinology, Center for Basic and Translational Obesity Research, Boston Children's Hospital, Boston, Massachusetts 02115, USA., Hwang J; Department of Cell Biology, Harvard Medical School, Boston, Massachusetts 02115, USA., DuBois CD; Division of Endocrinology, Center for Basic and Translational Obesity Research, Boston Children's Hospital, Boston, Massachusetts 02115, USA.; Broad Institute of Harvard and MIT, Cambridge, Massachusetts 02142, USA., Coloff JL; Department of Cell Biology, Harvard Medical School, Boston, Massachusetts 02115, USA., Hitchcock DS; Broad Institute of Harvard and MIT, Cambridge, Massachusetts 02142, USA., Clish CB; Broad Institute of Harvard and MIT, Cambridge, Massachusetts 02142, USA., Brugge JS; Department of Cell Biology, Harvard Medical School, Boston, Massachusetts 02115, USA., Kalaany NY; Division of Endocrinology, Center for Basic and Translational Obesity Research, Boston Children's Hospital, Boston, Massachusetts 02115, USA.; Broad Institute of Harvard and MIT, Cambridge, Massachusetts 02142, USA.; Department of Pediatrics, Harvard Medical School, Boston, Massachusetts 02115, USA.
Publikováno v:
Nature communications [Nat Commun] 2017 Jan 10; Vol. 8, pp. 13989. Date of Electronic Publication: 2017 Jan 10.
Autor:
Iwanicki MP; Department of Cell Biology, Harvard Medical School, Boston, Massachusetts, USA., Chen HY; Department of Cell Biology, Harvard Medical School, Boston, Massachusetts, USA., Iavarone C; Department of Cell Biology, Harvard Medical School, Boston, Massachusetts, USA., Zervantonakis IK; Department of Cell Biology, Harvard Medical School, Boston, Massachusetts, USA., Muranen T; Department of Cell Biology, Harvard Medical School, Boston, Massachusetts, USA., Novak M; Dana-Farber Cancer Institute, Department of Medical Oncology, Center for Molecular Oncologic Pathology, Boston, Massachusetts, USA., Ince TA; Stem Cell Institute, University of Miami Miller School of Medicine, Miami, Florida, USA., Drapkin R; Dana-Farber Cancer Institute, Department of Medical Oncology, Center for Molecular Oncologic Pathology, Boston, Massachusetts, USA.; Penn Ovarian Cancer Research Center, Basser Center for BRCA, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Brugge JS; Department of Cell Biology, Harvard Medical School, Boston, Massachusetts, USA.
Publikováno v:
JCI insight [JCI Insight] 2016 Jul 07; Vol. 1 (10).
Autor:
Vakifahmetoglu-Norberg H, Kim M, Xia HG, Iwanicki MP, Ofengeim D, Coloff JL, Pan L, Ince TA, Kroemer G, Brugge JS, Yuan J
Publikováno v:
Genes & development [Genes Dev] 2016 Apr 01; Vol. 30 (7), pp. 870.
Mesenchymal gene program-expressing ovarian cancer spheroids exhibit enhanced mesothelial clearance.
Autor:
Davidowitz RA, Selfors LM, Iwanicki MP, Elias KM, Karst A, Piao H, Ince TA, Drage MG, Dering J, Konecny GE, Matulonis U, Mills GB, Slamon DJ, Drapkin R, Brugge JS
Publikováno v:
The Journal of clinical investigation [J Clin Invest] 2014 Jun; Vol. 124 (6), pp. 2611-25. Date of Electronic Publication: 2014 Apr 24.
Autor:
Maninová M; Cell and Molecular Microbiology Division; Institute of Microbiology; Prague, Czech Republic., Iwanicki MP; Department of Cell Biology; Harvard Medical School; Boston, MA USA., Vomastek T; Cell and Molecular Microbiology Division; Institute of Microbiology; Prague, Czech Republic.
Publikováno v:
Cell adhesion & migration [Cell Adh Migr] 2014; Vol. 8 (1), pp. 42-8. Date of Electronic Publication: 2013 Jan 01.